Novel therapies under investigation for mantle cell lymphoma

被引：3
作者：
Robak, Tadeusz [1 ]
机构：
[1] Med Univ Lodz, Copernicus Mem Hosp, Dept Hematol, Lodz, Poland
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2016年 / 25卷 / 04期
关键词：
PHASE-II; UNITED-STATES; BORTEZOMIB; LENALIDOMIDE; MONOTHERAPY; RITUXIMAB; IBRUTINIB; MUTATION; TRENDS; NOTCH1;
D O I：
10.1517/13543784.2016.1152259
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：375 / 380
页数：6
相关论文
共 33 条
[31]   Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial [J].
Westin, Jason R. ;
Chu, Fuliang ;
Zhang, Min ;
Fayad, Luis E. ;
Kwak, Larry W. ;
Fowler, Nathan ;
Romaguera, Jorge ;
Hagemeister, Fredrick ;
Fanale, Michelle ;
Samaniego, Felipe ;
Feng, Lei ;
Baladandayuthapani, Veerabhadran ;
Wang, Zhiqiang ;
Ma, Wencai ;
Gao, Yanli ;
Wallace, Michael ;
Vence, Luis M. ;
Radvanyi, Laszlo ;
Muzzafar, Tariq ;
Rotem-Yehudar, Rinat ;
Davis, R. Eric ;
Neelapu, Sattva S. .
LANCET ONCOLOGY, 2014, 15 (01) :69-77
[32]   Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib [J].
Woyach, Jennifer A. ;
Furman, Richard R. ;
Liu, Ta-Ming ;
Ozer, Hatice Gulcin ;
Zapatka, Marc ;
Ruppert, Amy S. ;
Xue, Ling ;
Li, Daniel Hsieh-Hsin ;
Steggerda, Susanne M. ;
Versele, Matthias ;
Dave, Sandeep S. ;
Zhang, Jenny ;
Yilmaz, Ayse Selen ;
Jaglowski, Samantha M. ;
Blum, Kristie A. ;
Lozanski, Arletta ;
Lozanski, Gerard ;
James, Danelle F. ;
Barrientos, Jacqueline C. ;
Lichter, Peter ;
Stilgenbauer, Stephan ;
Buggy, Joseph J. ;
Chang, Betty Y. ;
Johnson, Amy J. ;
Byrd, John C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24) :2286-2294
[33]   Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004 [J].
Zhou, Yuhong ;
Wang, Haijun ;
Fang, Wenjing ;
Romaguer, Jorge E. ;
Zhang, Yanxia ;
Delasalle, Kay B. ;
Kwak, Larry ;
Yi, Oing ;
Du, Xianglin L. ;
Wang, Michael .
CANCER, 2008, 113 (04) :791-798
1234